Kentucky Senate Bill 134 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 3-0)
Status: Introduced on February 2 2022 - 25% progression, died in committee
Action: 2022-02-07 - to Banking & Insurance (S)
Pending: Senate Banking and Insurance Committee
Text: Latest bill text (Introduced) [PDF]

Amend KRS 304.17A-164 to establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with the prescription drugs cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; create a new section of Subtitle 17C of KRS Chapter 304 to apply the cost-sharing and rebate requirements for prescription drugs to limited health service benefit plans and limited health service contracts; create a new section of Subtitle 38A of KRS Chapter 304 and amend KRS 18A.225 and 164.2871 to require limited health service organizations, the state employee health plan, and self-insured employer group health plans provided by the governing board of a state postsecondary education institution to comply with the cost-sharing and rebate requirements for prescription drugs; apply to health plans issued or renewed on or after the effective date of the Act; EFFECTIVE January 1, 2023.

AN ACT relating to prescription drugs.

Sen. Stephen Meredith [R]

Sen. Ralph Alvarado [R]

Sen. Danny Carroll [R]

Date	Chamber	Action
2022-02-07	Senate	to Banking & Insurance (S)
2022-02-02	Senate	to Committee on Committees (S)
2022-02-02	Senate	introduced in Senate

Type	Source
Summary	https://apps.legislature.ky.gov/record/22RS/sb134.html
Text	https://apps.legislature.ky.gov/recorddocuments/bill/22RS/sb134/orig_bill.pdf